secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2025-04-11T23:59:59+00:00
Accession:  0001641489-25-000018
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics appoints Barry K. Brown as interim principal financial officer
-------------------------------------------------------------------------------

- Barry K. Brown, 64, appointed interim principal financial officer effective April 11, 2025; continues as chief accounting officer.
- Salary remains unchanged at $231,000 per year during the interim role.
- Brown previously served as interim CFO from March to December 2022 and as controller since 2000.
- Company is conducting an external search for a permanent chief financial officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148925000018/0001641489-25-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148925000018/vtvt-20250411.htm
  HTML page:      https://secwatch.observer/filing/0001641489-25-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer